TEDCO Invests in JuneBrain, Inc.

COLUMBIA, Md., (September 10, 2024) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 Builder Fund investment in JuneBrain Inc., a biotechnology company. TEDCO’s Pre-Seed Builder Fund is part of TEDCO’s Social Impact Funds, which were created to engage and invest in economically underserved founders and communities.

“JuneBrain was originally started to creatively support patients and those who care for them,” said Dr. Samantha Scott, founder and CEO. “TEDCO’s continued investments in us have helped our goals and unique strategies come to fruition.”

JuneBrain Inc., located in Baltimore, Md., has amassed a network of team members mobilized nationwide. Their work focuses on both the ophthalmology and neurology sectors, as millions of individuals across the globe suffer from retinal and neurological diseases. JuneBrain’s mission is to offer unique solutions to address the gap of infrequent, objective monitoring. The company currently offers two products for investigational use only: a high-speed retinal imaging system nicknamed Neuro-i SS-OCT, and an AI software product designed to automatically analyze retinal images for neurodegenerative disease, named the JuneBrain Reading Center.

“JuneBrain continues to offer creative ideas to address diseases that affect millions of patients worldwide,” says Jean Luc-Park, senior director of TEDCO’s Social Impact Funds. “JuneBrain’s mission is one that TEDCO is dedicated to supporting.”

JuneBrain has previously received investments from TEDCO through the Pre-Seed Builder Fund and the State Small Business Credit Initiative (SSBCI).

For more information about the Pre-Seed Builder Fund and other investment opportunities at TEDCO, visit https://www.tedcomd.com/funding/social-impact-funds.